new indications for glp 1 drugs Orforglipron, approved as Foundayo on April 1, 2026, adds another oral GLP-1 option chronic weight management in adults with obesity or overweight plus at least one weight-related condition. The clinical relevance πNew GLP-1 pill gets FDA
Pay in 4 interest-free payments of $6.17 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Nov 19 - Nov 24


















